All In Biotech

Drug Trial Radar · NCT07894939

Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan Citrate

Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

3,000

Planned (sponsor's estimate)

Start

Nov 2, 2024

Primary completion

Dec 31, 2029

Study completion Dec 31, 2029

Sponsor

Lead sponsor
Jeil Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Oct 26, 2026

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post-marketing surveillance aims to evaluate the safety and effectiveness of zastaprazan citrate administered in Korean patients receiving the drug in accordance with the approved prescribing information.

Conditions

  • Erosive Gastroesophageal Reflux Disease

Interventions

  • zastaprazan citrateDrug

    There is no treatment allocation in this study. Patients who are prescribed zastaprazan citrate at the discretion of their treating physicians will be enrolled consecutively. Zastaprazan citrate will be administered in accordance with the approved prescribing information.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Adverse EventsTime frame: From enrollment to the end of treatment at 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seoul National University BORAMAE Medical Center

    Seoul, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.